从癌症注册数据中高估了多发性骨髓瘤生存率
John H Huber1, Mei Wang1,2,3, Rong Wang4,5
1Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Journal of the National Cancer Institute
|February 7, 2026
概括
多发性骨髓瘤 (MM) 存活率统计数据被高估,因为它们包括燃烧的MM (SMM). 将症状性MM和SMM数据分开将改善管理和预防策略.
科学领域:
- 血液学 血液学 血液学
- 癌症流行病学 癌症流行病学
- 生物统计学 生物统计学
背景情况:
- 监测,流行病学和最终结果 (SEER) 多发性骨髓瘤 (MM) 存活率统计指导了临床管理.
- 这些统计数据可能是不准确的,因为它包含了燃烧的多发性髓瘤 (SMM),这是一个前体状况.
研究的目的:
- 为了估计SEER MM生存统计数据在多大程度上被高估,包括SMM.
- 倡导对症状性MM和SMM生存数据进行单独报告.
主要方法:
- 使用了最新的SEER数据发布.
- 分析了整体MM,症状MM和SMM的生存统计数据.
- 计算的中位生存率和五年相对生存率.
主要成果:
- 2016年,症状性MM占MM总病例的77.9%,SMM占MM总病例的10.9%.
- 总体MM的中位生存时间为65.8个月,而症状MM的中位生存时间为56.8个月.
- 包括SMM在内的MM存活率高估了9个月;SMM的五年相对存活率为88.3%,而症状MM的57.9%.
结论:
- 多发性骨髓瘤的SEER存活率统计数据被高估,原因是纳入了燃烧的多发性骨髓瘤.
- 单独报告症状MM和SMM的生存数据对于准确的人口层面管理和预防至关重要.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.5K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
9.1K
相关概念视频
Censoring Survival Data
555
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
555
Cancer Survival Analysis
769
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
769
Survival Curves
722
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
722
Survival Tree
433
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
433
Introduction To Survival Analysis
803
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
803
Comparing the Survival Analysis of Two or More Groups
607
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
607
